Skip to main content

Handelsbanken Fonder AB

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1398318 STOCKHOLM, V7

Position in RXRX

as of Jun 30, 2026 · filed Jul 10, 2026
Position Value
$762,993
+$428,670 QoQ
Shares Held
207,900
+90.9% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 58 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. RXRX ranks #82 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RXRX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $762,993 207,900
2026-03-31 $334,323 108,900
2025-12-31 $445,401 108,900
2025-09-30 $432,856 88,700
2025-06-30 $448,822 88,700
2025-03-31 $389,344 73,600
2024-12-31 $497,536 73,600
2024-09-30 $458,005 69,500
2024-06-30 $390,750 52,100
2024-03-31 $339,977 34,100
2023-12-31 $336,226 34,100
2023-09-30 $171,360 22,400
2023-06-30 $167,328 22,400
2023-03-31 $125,396 18,800
2022-12-31 $144,948 18,800
2022-09-30 $141,512 13,300
2022-06-30 $108,262 13,300
2022-03-31 $95,228 13,300
2021-12-31 $227,829 13,300